ArticleAnnals of hematology2026

Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in Japan.

Mitsuhiro Itagaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.